Zoetis/$ZTS

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Zoetis

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Ticker

$ZTS

Trading on

NYSE

Industry

Pharmaceuticals

Employees

13,800

ISIN

US98978V1035

Zoetis Metrics

BasicAdvanced
$75B
30.27
$5.57
0.94
$1.80
1.19%

What the Analysts think about Zoetis

Analyst ratings (Buy, Hold, Sell) for Zoetis stock.

Zoetis Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Zoetis Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ZTS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Jun3
Zoetis
Dividend·Payment
$0.50Per share
Jul18
Zoetis
Dividend·Ex-dividend
Sept3
Zoetis
Dividend·Payment
$0.50Per share
FAQs